Jingfeng Liu
South China Agricultural University(CN)Fujian Medical University(CN)Shanghai Jiao Tong University(CN)Capital Medical University(CN)Anhui Medical University(CN)Shanghai University of Electric Power(CN)Ruijin Hospital(CN)Beijing Shijingshan Hospital(CN)Southwestern Medical Center(US)Guangdong Provincial Hospital of Traditional Chinese Medicine(CN)Beijing Anding Hospital(CN)Mengchao Hepatobiliary Hospital(CN)Zhuhai Hospital of Integrated Traditional Chinese and Western Medicine(CN)First Affiliated Hospital of Anhui Medical University(CN)Beijing Friendship Hospital(CN)Fujian Provincial Cancer Hospital(CN)Center for Cancer Research(US)Shandong Institute of Commerce & Technology(CN)Southwestern Medical CenterThe University of Texas Southwestern Medical Center(US)South China University of Technology(CN)
Publications by Year
Research Areas
Hepatocellular Carcinoma Treatment and Prognosis, Liver Disease Diagnosis and Treatment, Nanoplatforms for cancer theranostics, Cholangiocarcinoma and Gallbladder Cancer Studies, Cancer Genomics and Diagnostics
Most-Cited Works
- → Camrelizumab in Combination with Apatinib in Patients with Advanced Hepatocellular Carcinoma (RESCUE): A Nonrandomized, Open-label, Phase II Trial(2020)556 cited
- → Chlorin e6 Conjugated Poly(dopamine) Nanospheres as PDT/PTT Dual-Modal Therapeutic Agents for Enhanced Cancer Therapy(2015)354 cited
- → Dual-Channel Photoelectrochemical Ratiometric Aptasensor with up-Converting Nanocrystals Using Spatial-Resolved Technique on Homemade 3D Printed Device(2018)326 cited
- → Circular RNAs negatively regulate cancer stem cells by physically binding FMRP against CCAR1 complex in hepatocellular carcinoma(2019)322 cited
- → α-Tocopheryl succinate induces apoptosis by targeting ubiquinone-binding sites in mitochondrial respiratory complex II(2008)294 cited
- → Effect of Huaier granule on recurrence after curative resection of HCC: a multicentre, randomised clinical trial(2018)